Evaluation of the Xpa-Deficient Transgenic Mouse Model for Short-Term Carcinogenicity Testing: 9-Month Studies with Haloperidol, Reserpine, Phenacetin, and D-Mannitol

By LINA BEN   WOUTERSEN RUUD   BRUIJNTJES JOOST   BENTHEM JAN   Berg JOLANDA   MONBALIU JOHAN   THOOLEN BOB   BEEMS RUDOLF   KREIJL COEN  

Toxicologic Pathology, Vol. 32, Iss. 2, 2004-03 ,pp. : 192-201

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expectations for Transgenic Rodent Cancer Bioassay Models

By Ashby John  

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 177-182

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Molecular Mechanisms of Hepatocarcinogenesis in Transgenic Mouse Models of Liver Cancer

By Calvisi Diego   Thorgeirsson Snorri  

Toxicologic Pathology, Vol. 33, Iss. 1, 2005-01 ,pp. : 181-184

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The rasH2 Transgenic Mouse: Nature of the Model and Mechanistic Studies on Tumorigenesis

By Tamaoki Norikazu  

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 81-89

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Evaluation of 89 Zr-rituximab Tracer by Cerenkov Luminescence Imaging and Correlation with PET in a Humanized Transgenic Mouse Model to Image NHL

By Natarajan Arutselvan  

Molecular Imaging and Biology, Vol. 15, Iss. 4, 2013-08 ,pp. : 468-475

Springer Publishing Company

Access to resources Recommend Favorite